Ozempic and semaglutide are often used as if they meant the same thing, but they refer to different concepts.
What is Ozempic?
Ozempic is the protected name of a regulated pharmaceutical product containing semaglutide, with its own formulation, manufacturing standards and labeling.
What is semaglutide?
Semaglutide is the name of the active GLP-1 receptor agonist molecule. The molecular name does not mean that every material is Ozempic or that it has the same regulatory status or characteristics as an approved medicine.
Is every semaglutide product Ozempic?
No. Ozempic identifies a specific branded medicine. Semaglutide identifies the active molecule. This distinction matters when interpreting research, analytical documentation and regulatory claims.
Peptiva research context
Peptiva does not sell Ozempic. The neutrally labeled GLP1 Reference Specimen is a separate laboratory material for analytical and in-vitro research.
What should be checked?
- declared molecular identity
- purity according to the stated analytical method
- material quantity
- batch-specific documentation
- limitations of each analytical test
Sources
FDA regulatory information and current documentation for semaglutide-containing medicines.
RESEARCH USE ONLY: This educational content concerns laboratory and scientific research. Peptiva research materials are not medicines and are not intended for use in humans or animals.